Dr Manju Chandran – inaugural Chair of the Asia Pacific Consortium on Osteoporosis (APCO)

Dr Manju Chandran, a leader in the fields of Endocrinology and Bone Metabolism, is the Inaugural Chair of the Asia Pacific Consortium on Osteoporosis (APCO). Dr Chandran currently serves as a Senior Consultant Endocrinologist and Director of the Osteoporosis and Bone Metabolism  Unit that she set up at Singapore General Hospital in 2007. After completing…

Read More

The role of strategic communications in helping to navigate unchartered COVID-19 waters

Our very own VIVA! Communications Principal and owner, Kirsten Bruce, Sydney was recently quoted in pharmaceutical industry publication, Pharma in Focus on how to engage with staff while working from home during the current COVID-19 pandemic. Today, Kirsten shares further insights on how companies should communicate both internally and externally in this challenging, unchartered landscape.…

Read More

Aussies & Kiwis with incurable blood cancer receive newly subsidised treatment option

Today, VIVA! partnered with Celgene, a Bristol-Myers Squibb company, Multiple Myeloma Australia and Multiple Myeloma New Zealand to announce a newly reimbursed treatment option for Australians and New Zealanders living with incurable blood cancer, multiple myeloma. REVLIMID® (lenalidomide) – the first and only maintenance treatment in ANZ specifically indicated and reimbursed for those with newly…

Read More

1 in 10 Aussies with epilepsy sustaining serious physical injuries

VIVA! Communications is delighted to be teaming with UCB today (Thursday, March 26, 2020) to highlight the serious injuries caused by epileptic seizures, and call for heightened awareness, understanding and support for the 250,000 Australians living with epilepsy. One in 10 Australians living with epilepsy experience a seizure-related injury each year, many of which are…

Read More